Cargando…

Insulin Resistance in Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is one of the readily recognised endocrine gland illnesses in women, with an incidence range from 2.2% to 26% in India. Patients experiencing PCOS experience issues involving irregular menstrual periods, hirsutism, acne, being overweight, and impotence. Long-term,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Purwar, Ananya, Nagpure, Shailesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Endocrinology/Diabetes/Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665922/ https://www.ncbi.nlm.nih.gov/pubmed/36407241 http://dx.doi.org/10.7759/cureus.30351

Ejemplares similares

Insulin Resistance, Hyperandrogenism, and Its Associated Symptoms Are the Precipitating Factors for Depression in Women With Polycystic Ovarian Syndrome
por: Ethirajulu, Aarthi, et al.
Publicado: (2021)

Polycystic Ovarian Syndrome in Adolescents
por: Adone, Avanti, et al.
Publicado: (2023)

Polycystic Ovarian Syndrome in Aging Women: An Observational Study
por: Agarwal, Mukta, et al.
Publicado: (2022)

The Effect of Insulin Resistance on Ovulation Induction With Clomiphene Citrate in Non-polycystic Ovary Syndrome (PCOS) Women
por: Karnatak, Ruchi, et al.
Publicado: (2022)

Polycystic Ovarian Syndrome: An Autobiographical Case Report of an Often Overlooked Disorder
por: Patel, Vithi Hitendra
Publicado: (2022)

Cardio-Metabolic Disease and Polycystic Ovarian Syndrome (PCOS): A Narrative Review
por: Sangaraju, Sai Lahari, et al.
Publicado: (2022)

Prevalence of Polycystic Ovarian Syndrome in India: A Systematic Review and Meta-Analysis
por: Bharali, Mintu Dewri, et al.
Publicado: (2022)

Effects of Metformin on Symptoms of Polycystic Ovarian Syndrome Among Women of Reproductive Age
por: Artani, Moiz, et al.
Publicado: (2018)

Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review
por: Bodepudi, Ranita, et al.
Publicado: (2023)

Visceral Adiposity Index as an Indicator for Menstrual Disturbance, Hormonal and Metabolic Dysfunction in Polycystic Ovarian Syndrome
por: Sharma, Priyanka, et al.
Publicado: (2022)

Oxidative Stress in Polycystic Ovarian Syndrome and the Effect of Antioxidant N-Acetylcysteine on Ovulation and Pregnancy Rate
por: Sandhu, Jasmine K, et al.
Publicado: (2021)

Spironolactone Versus Oral Contraceptive Pills in the Treatment of Adolescent Polycystic Ovarian Syndrome: A Systematic Review
por: Rajashekar, Shriya, et al.
Publicado: (2022)

Metabolic, Hormonal, Immunologic, and Genetic Factors Associated With the Incidence of Thyroid Disorders in Polycystic Ovarian Syndrome Patients
por: Singh, Jaya, et al.
Publicado: (2020)

Diabetes, Polycystic Ovarian Syndrome, Obstructive Sleep Apnea, and Obesity: A Systematic Review and Important Emerging Themes
por: Bambhroliya, Zarna, et al.
Publicado: (2022)

Effect of Metformin (MTF) Intervention During Pregnancy in Women With Polycystic Ovarian Syndrome (PCOS): A Systematic Review
por: Kanda, Srishti, et al.
Publicado: (2023)

A Comparative Study of Luteinizing Hormone Levels in Polycystic Ovarian Syndrome With Hyperandrogenism: Metformin Versus Oral Contraceptive Pills
por: Fattah, Abdul, et al.
Publicado: (2022)

Frequency of Subclinical Hypothyroidism in Women With Polycystic Ovary Syndrome
por: Raj, Deepak, et al.
Publicado: (2021)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Type 2 Diabetes Mellitus in Patients With Polycystic Ovary Syndrome
por: Agrawal, Anjali, et al.
Publicado: (2023)

Polycystic Ovary Syndrome Among Female Adolescents With Congenital Adrenal Hyperplasia
por: Abdelhamed, Marwa H, et al.
Publicado: (2021)

Risk of Gynecological Cancers in Women With Polycystic Ovary Syndrome and the Pathophysiology of Association
por: Shetty, Chaitra, et al.
Publicado: (2023)

Influence of Subclinical Hypothyroidism on Women With Polycystic Ovary Syndrome: A Literature Review
por: Peddemul, Aishwarya, et al.
Publicado: (2022)

Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
por: Layacha, Sakshi Y, et al.
Publicado: (2023)

Why are Women With Polycystic Ovary Syndrome at Increased Risk of Depression? Exploring the Etiological Maze
por: Gnawali, Anupa, et al.
Publicado: (2021)

Müllerian Duct Anomalies and Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome
por: Yang, Min, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: A Literature Review With a Focus on Diagnosis, Pathophysiology, and Management
por: Waghmare, Shrutika V, et al.
Publicado: (2023)

Comparison of Novel Biomarkers of Insulin Resistance With Homeostasis Model Assessment of Insulin Resistance, Its Correlation to Metabolic Syndrome in South Indian Population and Proposition of Population Specific Cutoffs for These Indices
por: Jog, Komal S, et al.
Publicado: (2023)

Association of Leptin With Obesity and Insulin Resistance
por: Kumar, Ratan, et al.
Publicado: (2020)

Frank’s Sign in Polycystic Ovary Syndrome and Sideburn Adiposity: A Case Report and Illustrated Hypothesis
por: Abrahim, Mohammed
Publicado: (2021)

Clinical Presentation and Frequency of Metabolic Syndrome in Women With Polycystic Ovary Syndrome: An Experience From a Tertiary Care Hospital in Pakistan
por: Anjum, Sarwat, et al.
Publicado: (2020)

Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study
por: Mishra, Neha, et al.
Publicado: (2022)

Idiopathic Hyperprolactinemia Presenting as Polycystic Ovary Syndrome in Identical Twin Sisters: A Case Report and Literature Review
por: Goyal, Alpesh, et al.
Publicado: (2018)

The Hidden Threat: Endocrine Disruptors and Their Impact on Insulin Resistance
por: Dagar, Mehak, et al.
Publicado: (2023)

Comparison of Serum Vitamin B12 Levels Among Drug-Naïve and Metformin-Treated Patients With Polycystic Ovary Syndrome
por: Kamrul-Hasan, ABM, et al.
Publicado: (2022)

Myo-Inositol’s Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome
por: Gupta, Deepti, et al.
Publicado: (2020)

Evaluation of the Salivary Matrix Metalloproteinase-9 in Women With Polycystic Ovaries Syndrome and Gingival Inflammation: A Case-Control Study
por: Maboudi, Avideh, et al.
Publicado: (2023)

Hyponatremia: An Untimely Finding in Ovarian Hyper-Stimulation Syndrome
por: Elmahal, Mohammed, et al.
Publicado: (2021)

Spontaneous Ovarian Hyperstimulation Syndrome Associated With Primary Hypothyroidism
por: Alzebidi, Jawharah A, et al.
Publicado: (2023)

Effect of Prebiotic Dietary Supplement Acacia senegal on Hormonal and Metabolic Markers in Polycystic Ovary Syndrome Patients: A Pilot Study
por: Mohamed, Reem I, et al.
Publicado: (2023)

Development of the First Health-Related Quality of Life Questionnaires in Arabic for Women With Polycystic Ovary Syndrome (Part III): Scoring System Interpretation
por: Odhaib, Samih A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4pivigri8k5kcqrvab88iivps